Life Sciences
The strategy is focused on creating and building life science companies addressing significant unmet needs for patients with limited or no treatment options.
The senior members of the team have a 20+ year track record of building successful life science companies relevant to this strategy. The team has deep operational experience in drug discovery and development.
Regions
- Western Europe
- United States
Portfolio companies and realisations
The Life Sciences strategy aims to build a portfolio of c.15 to 20 preclinical and clinical stage growth opportunities with equity investments of $20-100m per company.
Life Sciences in ICG Client Lounge
Find out more about this strategy within our digital hub for clients and consultants.
Explore
Life Sciences events calendar
(Year)
Date
Event
Website
2025
12 May 2025
ICG Life Sciences team attends Bio€quity Europe 2025 in Bruges (to 14 May)12 May 2025
2025
17 Mar 2025
ICG Life Sciences team attends BIO-Europe Spring in Milan (to 19 Mar)17 Mar 2025
2025
26 Feb 2025
ICG Life Sciences team attends Sachs' 18th Annual European Life Sciences CEO Forum in Zurich (to 27 Feb)26 Feb 2025
2025
13 Jan 2025
ICG Life Sciences team attends JP Morgan Healthcare Conference in San Francisco (to 16 Jan)13 Jan 2025
2024
20 Nov 2024
Head of Life Sciences Dr Allan Marchington takes part in panel discussion at Jefferies London Healthcare Conference 202420 Nov 2024
2024
18 Nov 2024
Head of Life Sciences Dr Allan Marchington takes part in panel discussion -- 'What investors want: The key criteria investors really care about when making investment decisions' -- at 12th annual ICR Healthcare Conference in London18 Nov 2024
2024
13 Nov 2024
Head of Life Sciences Dr Allan Marchington speaks on a panel called 'Can pension Funds Fuel the Growth of Life Sciences' at the Mansion House Compact breakfast13 Nov 2024
2024
12 Nov 2024
Tracy Weightman, Associate Director, takes part in panel discussion 'Charting the pathways to patient impact: the role of start-ups in oncology innovation' at the Cancer Research Horizons Innovation Summit in Edinburgh12 Nov 2024
2024
22 Oct 2024
Head of Life Sciences Dr Allan Marchington speaks at conference entitled 'SPS Local Authority Pension Funds' ESG & Current Issues', at The View, Royal College of Surgeons, London22 Oct 2024
2024
10 Oct 2024
Head of Life Sciences Dr Allan Marchington joins panel discussion, 'What’s happening in the markets? M&A, IPO, Private Financing', at Optimum 16th Annual Healthcare Investor Conference10 Oct 2024
2024
07 Oct 2024
Dr Allan Marchington hosts a webinar on 'Venture Capital to the Prostate Cancer Research Charity and the importance of Charities in the Life Science Ecosystem'07 Oct 2024
2024
01 Aug 2024
Head of Life Sciences Dr Allan Marchington participates in CAMRADATA Healthcare roundtable01 Aug 2024
2024
22 May 2024
Head of Life Sciences Dr Allan Marchington participate in a Fireside discussion, 'The Venture capital Investment Compact - Building long-term partnerships between pension schemes and private capital fund managers', at the BVCA's conference, Accelerate: Angel Investors, Venture & Growth Equity22 May 2024
2024
24 Apr 2024
Head of Life Sciences Dr Allan Marchington takes part in panel entitled 'What does a good deal look like & what Investors (really) want' at BioTrinity in London24 Apr 2024
2024
18 Apr 2024
Head of Life Sciences Dr Allan Marchington takes part in panel discussing 'Trends in Life Science Investments' at the 20th Anglonordic Life Sciences conference in London18 Apr 2024
2024
19 Mar 2024
Life Sciences Associate Director Tracy Weightman takes part in panel discussion 'New Generation of Life Science Venture Investing' at Bio-Europe Spring in Barcelona, Spain19 Mar 2024
2024
28 Feb 2024
Head of Life Sciences Dr Allan Marchington speaks at 17th Annual European Life Sciences CEO Forum, Hilton Zurich Airport Hotel28 Feb 2024
2023
07 Dec 2023
Head of Life Sciences Dr Allan Marchington attends London Impact Investing Network’s (LIIN) event – Approaches to Impact in Healthcare – at Quintet Private Bank, London 07 Dec 2023
2023
29 Nov 2023
Head of Life Sciences Dr Allan Marchington takes part in panel - 'Making the UK an international powerhouse - Joining the North and South' - at Bruntwood SciTech Seminar29 Nov 2023
2023
19 Oct 2023
Life Sciences Managing Director Simon Tate speaks at SPS LGPS Sustainable Investment and Other Topical Issues conference at the Royal College of Surgeons, London19 Oct 2023
2023
11 Oct 2023
Head of Life Sciences Dr Allan Marchington takes part in panel -- UK life sciences is open for business -- at Optimum's 15th Annual Healthcare Investor Conference in London11 Oct 2023
2023
19 Sep 2023
Life Sciences Managing Director Toby Sykes attends IPEM Paris 202319 Sep 2023
2023
13 Jul 2023
ICG Life Sciences team sponsor and attend UK BioIndustry Association (BIA) Summer Party 202313 Jul 2023
2023
15 May 2023
Head of Life Sciences Dr Allan Marchington chairs panel 'The 12th Annual CEO Bootcamp: Are European Boards Fit for Purpose in the New Normal?' at BioEquity Europe in Dublin, Ireland 15 May 2023
2023
20 Apr 2023
Dr Allan Marchington, Head of Life Sciences and Tracy Weightman, Associate Director, attend ANGLONORDIC Life Sciences Conference in London20 Apr 2023
2023
01 Apr 2023
ICG Life Sciences portfolio company CuraSen Therapeutics presents Phase 2 data at AD/PD 2023, the International Conference on Alzheimer's and Parkinson's Diseases and related neurological disorders01 Apr 2023
2023
29 Mar 2023
Life Sciences Managing Director Simon Tate attends AD/PD 2023, the International Conference on Alzheimer's and Parkinson's Diseases and related neurological disorders29 Mar 2023
2023
16 Jan 2023
Life Sciences Managing Director Toby Sykes attends TABOR Family Office Conference16 Jan 2023
2023
09 Jan 2023
Life Sciences Managing Director Toby Sykes and Consultant Peter Kiener attend 41st Annual J.P. Morgan Annual Health Care Conference09 Jan 2023
2022
09 Nov 2022
Life Sciences Managing Director Simon Tate delivers talk on the history of drug discovery and treatments in pain research at British Neuroscience Association conference09 Nov 2022
2022
21 Sep 2022
Head of Life Sciences Dr Allan Marchington speaks during the State of the Industry Panel at the 22nd Annual Biotech in Europe Forum (BEF)21 Sep 2022
2022
26 May 2022
Life Sciences Associate Director Tracy Weightman speaks at Cancer Research UK Innovation Summit 202226 May 2022
Meet the Life Sciences team
Related people
Explore our portfolio companies
CuraSen Therapeutics
CuraSen Therapeutics is a clinical-stage company developing small molecule therapies to treat neurodegenerative disease.
Grey Wolf Therapeutics
Grey Wolf Therapeutics is a clinical-stage, drug discovery and development biotechnology company spearheading a new therapeutic approach
Wugen Inc
Wugen, Inc., is a clinical-stage biotechnology company developing the next generation of off-the-shelf memory natural killer (NK) and CAR-T cell therapies for cancer.
Successful realisations
Amolyt Pharma
Amolyt Pharma is a clinical stage biotechnology company working to deliver life-changing treatments to patients suffering from rare endocrine and related diseases.
Get in touch
To find out more about our flexible and sustainable solutions for both providers and users of capital, please contact us.
Contact us
